Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heartflow, Inc. - Common Stock (NQ:HTFL)

27.40 +1.91 (+7.49%)
Streaming Delayed Price Updated: 3:15 PM EDT, Jul 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Heartflow, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors? ↗
The medical technology company reported a notable insider sale in recent filings. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026? ↗
Heartflow boasts rapid AI-driven growth but faces reimbursement headwinds, while Omeros bets everything on its first commercial launch. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗
Heartflow scales AI diagnostics while Iovance drives personalized cancer therapies, each faces unique financial and operational risks in 2026. 
Via The Motley Fool
Topics Artificial Intelligence
Heartflow Inc (NASDAQ:HTFL) Beats Q1 Estimates and Hikes Full-Year Outlook, But Stock Slips After Hours ↗
Via Chartmill
News headline image
HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026? ↗
AI-powered diagnostics meet global oncology innovation as two medical disruptors post strong revenue growth, yet face distinct risk and valuation profiles. 
Via The Motley Fool
Topics Artificial Intelligence
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million? ↗
HeartFlow delivers AI-powered, non-invasive cardiac diagnostics for hospitals and cardiology clinics using proprietary imaging technology. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Heartflow Q1 Earnings Call Highlights ↗
Heartflow (NASDAQ:HTFL) reported a sharply higher first-quarter revenue total and raised its full-year 2026 outlook, citing strength in its core FFRCT business, faster-than-expected adoption of its... 
Via MarketBeat
Topics Artificial Intelligence Earnings
Heartflow Inc (NASDAQ:HTFL) Reports Strong Q4 Revenue Beat and Improved Margins Despite After-Hours Share Decline ↗
Via Chartmill
News headline image
Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
From Heartflow, Inc.
Via GlobeNewswire
News headline image
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
Issued on behalf of VentriPoint Diagnostics Ltd. 
From USA News Group
Via GlobeNewswire
News headline image
Wall Street Waits for the SpaceX IPO, These 2 Under-the-Radar IPOs Could Already Be Making You Money ↗
Heartflow and Neptune Insurance deserve a closer look. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering
TechMediaBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Advances AI Voice-Based Intoxication Detection as Real-Time Diagnostics Market Expands
Via Investor Brand Network
Topics Artificial Intelligence
The Future of Intoxication Detection May Be in Your Voice
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Stanford Trustees Exited HeartFlow Stock for $8.5 Million. Here's What That Means for Investors. ↗
HeartFlow provides AI-driven tools for non-invasive heart diagnostics, serving hospitals and clinics with advanced cardiovascular insights. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026
From Heartflow, Inc.
Via GlobeNewswire
News headline image
The Future of Intoxication Detection May Be in Your Voice
From BioMedWire
Via GlobeNewswire
News headline image
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
Issued on behalf of VentriPoint Diagnostics Ltd. 
From USA News Group
Via GlobeNewswire
News headline image
Heartflow Files Patent Infringement Lawsuit Against Cleerly
Heartflow asserts that Cleerly infringed foundational patented technology central to the Heartflow Platform 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale ↗
HeartFlow delivers AI-powered cardiac diagnostics to hospitals worldwide; a key insider recently trimmed their stake, SEC filings show. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares? ↗
HeartFlow delivers AI-powered, non-invasive cardiac diagnostics to healthcare providers seeking advanced imaging and decision support tools. 
Via The Motley Fool
News headline image
Heartflow Reports Fourth Quarter and Full Year 2025 Financial Results
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow Expands GAMEFILM Registry to NBA and NHL Alumni, Precisely Measuring Heart Disease Risk in Former Professional Athletes
NBA legend Muggsy Bogues joins effort to detect and manage coronary artery disease in retired players using AI-powered Heartflow Analysis 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
EXCLUSIVE: Aclarion CEO Looks To Bigger AI MedTech’s Playbook To Reverse Fortunes ↗
CEO Brent Ness noted a broad global market, with approximately 266 million people affected by chronic low back pain. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.
Fourth major national payer releases positive comprehensive coverage for AI-powered Heartflow Plaque Analysis 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
AI Diagnostics: The End of the High-Cost Imaging Era
Issued on behalf of VentriPoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.